Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting [Yahoo! Finance]
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting [Yahoo! Finance]